Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdCh63 ME-TRAP and MVA ME-TRAP Malaria Challenge Study
NCT00890760Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Mar 2009
- Primary completion
- Feb 2010
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ChAd63 ME-TRAP and MVA ME-TRAP in malaria (10 arms), sponsored by University of Oxford. Primary endpoint: Vaccine prevention (partial or complete) of malaria infection by sporozoite challenge. Started Mar 2009; status: completed.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00890760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890760.